Abiopharma

Rumble Announces Receipt of all Regulatory Approvals for Business Combination with Northern Data

NEUPATH HEALTH TO REPORT Q1 2026 RESULTS AND HOST INVESTOR WEBINAR

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Valvoline Inc. Becomes the First Ronald McDonald House Global Corporate Partner Dedicated Solely to Funding Mental Health Initiatives

Fortive To Present at 2026 Wolfe Research 19th Annual Global Transportation & Industrials Conference

Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer

Cambridge Financial Group, Inc. and First Seacoast Bancorp, Inc. Agree to Merge

Ballard Reports Q1 2026 Results USA - English USA - English

GD Culture Group Limited Announces Receipt of Preliminary Non-Binding Going Private Proposal at US$10.75 Per Share

Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance